Prevalence and prognostic impact of kidney disease on heart failure patients

Ida Löfman1, Karolina Szummer1, Inger Hagerman1

  • 1Department of Medicine, Section of Cardiology, Huddinge, Sweden; Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Open Heart
|February 6, 2016
PubMed

Insights

Kidney dysfunction is prevalent in heart failure patients and significantly increases mortality risk. This association remains strong across various patient subgroups and after adjusting for other health factors.

Area of Science:

  • Cardiology
  • Nephrology
  • Public Health

Background:

  • Heart failure (HF) is a complex condition with significant morbidity and mortality.
  • Kidney dysfunction is increasingly recognized as a critical factor influencing HF outcomes.
  • Understanding the prevalence and impact of kidney dysfunction in HF is crucial for patient management.

Purpose of the Study:

  • To determine the prevalence of varying degrees of kidney dysfunction in a large heart failure population.
  • To examine the association between kidney dysfunction and short-term and long-term outcomes in heart failure patients.
  • To assess the contribution of cardiac conditions to the prognostic value of kidney dysfunction in heart failure.

Main Methods:

  • Analysis of 47,716 patients from the Swedish Heart Failure Registry.
  • Stratification of patients into five renal function groups based on estimated glomerular filtration rate (eGFR).
  • Utilized Cox regression to analyze the adjusted association between kidney function and outcomes.

Main Results:

  • 51% of patients had eGFR <60 mL/min/1.73 m², with 11% having eGFR <30.
  • A consistent increase in mortality was observed with decreasing kidney function.
  • The elevated risk of mortality associated with kidney dysfunction persisted after adjusting for age, diabetes, NYHA class, HF duration, and hemoglobin levels.

Conclusions:

  • Kidney dysfunction is common in heart failure patients and strongly linked to adverse outcomes.
  • The association between kidney dysfunction and poor outcomes is robust across diverse patient characteristics and disease severity.
  • Kidney function is an independent prognostic marker in heart failure.
Abstract

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.2K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
927
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.1K